SCHEMBL22658192

SCHEMBL22658192

CC(=Cc1cccc(N)c1)CF

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 5/20 0.44
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
NPSR1 Q6W5P4 1/20 0.42
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
GFER P55789 1/20 0.40
CYP3A4 P08684 2/20 0.38
CASP1 P29466 1/20 0.38
RECQL P46063 1/20 0.38
NOS1 P29475 1/20 0.38
ALDH1A1 P00352 2/20 0.36
AKR1B1 P15121 2/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CA14 Q9ULX7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8867422 0.82 NPSR1 (0.46) CYP19A1MAOAMAOBNPSR1NPC1
SCHEMBL6770577 0.79 CYP19A1 (0.52) CYP19A1MAOAMAOBNPSR1NPC1
SCHEMBL13921161 0.77 CYP19A1 (0.50) CYP19A1MAOAMAOBNPSR1NPC1
SCHEMBL19921884 0.73 NPSR1 (0.47) CYP19A1MAOAMAOBNPSR1NPC1
SCHEMBL19915079 0.73 NPSR1 (0.47) CYP19A1MAOAMAOBNPSR1NPC1
SCHEMBL11435132 0.72 CYP19A1 (0.54) CYP19A1MAOAMAOBNPSR1NPC1
SCHEMBL10349539 0.71 AKR1C3 (0.63) CYP19A1MAOAMAOBNPSR1NPC1
SCHEMBL30529806 0.71 AKR1C3 (0.63) CYP19A1MAOAMAOBNPSR1NPC1
SCHEMBL10349537 0.71 AKR1C3 (0.63) CYP19A1MAOAMAOBNPSR1NPC1
SCHEMBL9065964 0.71 SLC9A1 (0.54) CYP19A1MAOAMAOBNPSR1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3983386-A1 ACSS2 INHIBITORS AND METHODS OF USE THEREOF Metabomed Ltd (IL) 2022-04-20 EP disclosed
WO-2020230136-A1 ACSS2 INHIBITORS AND METHODS OF USE THEREOF METABOMED LTD (IL) 2020-11-19 WO disclosed